I know you're no apologist for management anyway JD but i think right from the start unrealistic expectations were set around prostate therapy with the way they reported the complete response and then buried the rest for months.
Then you have the endless put downs of competitors and complete dismissal of their candidates as if Clarity's superiority is absolute and unequivocal.
Results needed to be spectacular to live up to the hype.
Then you have statements like; 'no-one else has a pipeline. They just don't. '
Complete dismissal of alpha therapy and then a u-turn to say we're doing it too.
I think this has eroded confidence in the stock somewhat and we're seeing that reflected in the SP now, not necessarily something which can be attributed to the DLT.
Then Trump's bullshit on top makes it easier to be a seller.
CU6 Price at posting:
$2.97 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)